Home
overview

For those working in the pharmaceuticals and diagnostics industry, understanding the strategic importance of new technologies and how they affect the marketplace is vital. This 3rd annual conference will provide attendees with a unique opportunity to hear detailed case study presentations on the latest diagnostic and testing technologies from leading pharmaceutical and diagnostic companies such as GE HealthCare, Roche Near Patient Testing, Bayer Healthcare, GlaxoSmithKline and Astrazeneca.

Leading industry speakers will give an invaluable and up-to-date overview of the global diagnostics market, including recent regulations and policies, the latest commercial issues in the industry along with successful product developments and an assessment of the opportunities that exist for diagnostic companies of the future.

This conference will enhance your knowledge and understanding of the fundamental issues within this key industry sector, giving you a key advantage in a highly competitive environment.

This is a great opportunity to learn from industry experts:

  • Harald Stock, Senior Vice President, Roche Near Patient Testing
  • Dr Christoph Petry, Head, Diagnostics Research, Bayer Healthcare
  • Dr Chris Reilly, Vice President & Head, Global Discovery Venture, AstraZeneca
  • Ian McLellan, Strategic Marketing, Molecular Diagnostics, GE Healthcare
  • Dr Linda Surh, Director, Regulatory Affairs, Neurology and Pharmacogenetics, GlaxoSmithKline
  • Dr David Horwitz, Worldwide Vice President, Medical & Clinical Affairs, LifeScan
  • Dr Kenneth Aron, Vice President, Research & Development, Abaxis
  • Kenneth Finnegan, Vice President, Quest Diagnostics
  • Karen Howes, Director, Regulatory Affairs, European Diagnostic Manufacturers Association (EDMA)
  • Dr Ian Barnes, Head, Pathology & National Pathology Clinical Lead, Leeds Teaching Hospital
  • Dr Thomas Mann, Managing Director, Direct Health First

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Paula Wittels

Paula Wittels, Director of Operations, Quintiles

9:10 THE CHANGING FACE OF THE HEALTHCARE MARKET

Ian Barnes

Ian Barnes, Head of Pathology & National Pathology Clinical Lead, Leeds Teaching Hospitals

  • Changes in service requirements
  • How this impacts on the diagnostics industry
  • Maximising on the opportunities
  • The need for pathology service reconfiguration
  • The NHS and the independent sector
  • 9:50 KEY OPPORTUNITIES IN IVDs

    Alex Wong

    Alex Wong, Industry Manager, Drug Discovery & Diagnostic Technologies, Frost and Sullivan

  • Current market overviews
  • Key challenges in IVD EU and APAC
  • What's hot - what's not? EU vs APAC
  • 10:30 Morning Coffee

    11:00 PHARMACOGENETICS (Pgx)

    Linda Surh

    Linda Surh, Director, Regulatory Affairs, Neurology and Pharmacogenetics, GlaxoSmithKline

  • What is Pgx and its drivers?
  • Healthcare applications - Pgx in action
  • Ethical and societal considerations
  • Regulatory implications - Reducing trial and error
  • 11:40 PREDICTIVE CANCER DIAGNOSTICS – OPPORTUNITIES AND TECHNOLOGIES

    Christoph Petry

    Christoph Petry, Head, Diagnostics Research Germany, Bayer HealthCare AG

  • Diagnostic markers to custom-tailor therapy regimen – facts and opportunities
  • Molecular diagnostics to guide therapies
  • Assay technologies for personalised medicine in the clinical practice
  • 12:20 Networking Lunch

    13:50 BLOOD TESTING FOR 2005

  • Advances in marrying therapeutics with diagnostics
  • Potential advances in leukaemia testing
  • How the new technology will impact oncology diagnostics
  • Kenneth Finnegan

    Kenneth Finnegan, Corporate Vice President, Business Development, Quest Diagnostics Inc.

    Richard Bender

    Richard Bender, Medical Director International, Quest Diagnostics

    14:30 CASE STUDY: LIFESCAN

    David Horwitz

    David Horwitz, Worldwide Vice President, Medical and Clinical Affairs, LifeScan

  • The latest advancements summarised
  • Current product offerings and their performance
  • Where the opportunities and limitations lie
  • An insight into future trends
  • 15:10 Afternoon Tea

    15:40 OPPORTUNITIES AND TRENDS IN MOLECULAR DIAGNOSTICS

    Ian McLellan

    Ian McLellan, Strategic Marketing, Molecular Diagnostics, GE Healthcare

  • Developing trends in procedures and practices
  • Creating integration of molecular and in vivo diagnostics
  • Technology limitations and opportunities
  • Towards clinical convergence – what will it take?
  • 16:20 PERSONALISED MEDICINE

    Stephen Little

    Stephen Little, Chief Executive Officer, DxS

  • An update on regulatory issues
  • Current and future products to market
  • Market growth potential – sector analysis
  • Leveraging current applications
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    Paula Wittels

    Paula Wittels, Director of Operations, Quintiles

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Stephen Little

    Stephen Little, Chief Executive Officer, DxS

    9:10 UPDATE ON REGULATORY AFFAIRS IN USA

    Thomas Soriano

    Thomas Soriano, President & Chief Executive Officer, Diagnostic Oncology CRO

  • Current FDA regulatory policies
  • Changes in FDA’s policies
  • Update on FDA product review cycles and performances
  • Vile gossip
  • 9:50 EUROPEAN ISSUES

    Karen Howes

    Karen Howes, Director Regulatory Affairs , European Diagnostics Manufacturers Association

  • Features of the correct system
  • -Current production issues

    -Design issues

  • Regulatory challenges
  • -Revision of the MDD impact on the IVDD

    -Environmental legislation

    -Animal by products

  • EU implementation
  • -By current member states

    -Accession countries

    -Next wave

  • Global issues
  • -Global harmonisation task force

    -Acceptance of the CE mark

    -Current production issues

    -Design issues

    10:30 Morning Coffee

    11:00 PANEL DISCUSSION

  • Measures to overcome constraints
  • Raising the awareness of the benefits of accurate testing
  • How well will diagnostic testing be adopted in the pharmaceutical industry?
  • Kenneth Aron, Ph.D.

    Kenneth Aron, Ph.D., Vice President, Research & Development, Abaxis

    David Horwitz

    David Horwitz, Worldwide Vice President, Medical and Clinical Affairs, LifeScan

    Stephen Little

    Stephen Little, Chief Executive Officer, DxS

    11:40 PRICING AND REIMBURSEMENT

    Thomas Mann

    Thomas Mann, Clinical Director, Department of Health

  • Developing effective pricing strategies
  • Considerations in structure and organisation
  • Assessing the legislation reforms
  • Future issues and problems to consider
  • 12:20 Networking Lunch

    13:50 THE CHANGING WORLD OF DIAGNOSTICS AND PERSONALISED MEDICINE

    Chris Reilly

    Chris Reilly, Vice President & Head, Global Drug Discovery Venture, AstraZeneca

  • Past investments
  • Recent investments
  • Current trends and developments
  • Issues moving forward
  • 14:30 LEVERAGING HOSPITAL POINT OF CARE OPPORTUNITIES

    Stefan Bluemmers

    Stefan Bluemmers, Head of Medical Marketing, Roche Diagnostics

  • Health economic benefits
  • Market trends in hospital point of care
  • Technology options and the role of connectivity
  • Making it happen
  • 15:10 Afternoon Tea

    15:40 POINT OF CARE TECHNOLOGY

    Gary Thorpe

    Gary Thorpe, Biochemistry Director, Wolfson Applied Technology Laboratory

  • Analysing the vast number of systems available
  • An overview of interesting technology developments
  • Product developments covering diverse application
  • 16:20 POINT OF CARE PRODUCT DEVELOPMENTS

    Kenneth Aron, Ph.D.

    Kenneth Aron, Ph.D., Vice President, Research & Development, Abaxis

  • The range of products on the market
  • Implications on the wider diagnostics marketplace
  • Market analysis – the leading suppliers
  • Benefits of POCT
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    Stephen Little

    Stephen Little, Chief Executive Officer, DxS

    +

    Workshops

    Point Of Care Testing: A Growing Market Segment - Myth or Reality?
    Workshop

    Point Of Care Testing: A Growing Market Segment - Myth or Reality?

    Millennium Gloucester Hotel
    28th June 2005
    London, United Kingdom

    Is Diagnostics on the Fast Track to Future Growth?
    Workshop

    Is Diagnostics on the Fast Track to Future Growth?

    Millennium Gloucester Hotel
    28th June 2005
    London, United Kingdom

    Millennium Gloucester Hotel

    Harrington Gardens
    London SW7 4LH
    United Kingdom

    Millennium Gloucester Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.